LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,000 | 0.0% | 119 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $12,000 | -14.3% | 119 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $14,000 | -6.7% | 119 | 0.0% | 0.01% | +20.0% |
| Q1 2019 | $15,000 | -6.2% | 119 | 0.0% | 0.01% | -37.5% |
| Q4 2018 | $16,000 | -51.5% | 119 | 0.0% | 0.01% | -38.5% |
| Q3 2018 | $33,000 | +32.0% | 119 | 0.0% | 0.01% | +30.0% |
| Q2 2018 | $25,000 | +25.0% | 119 | 0.0% | 0.01% | +11.1% |
| Q1 2018 | $20,000 | +25.0% | 119 | 0.0% | 0.01% | +12.5% |
| Q4 2017 | $16,000 | 0.0% | 119 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $16,000 | +14.3% | 119 | 0.0% | 0.01% | +14.3% |
| Q2 2017 | $14,000 | +7.7% | 119 | 0.0% | 0.01% | -12.5% |
| Q1 2017 | $13,000 | – | 119 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |